Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 6, keine Gesamtzahl für „Brukinsa“
Suchtreffer
Begriffe & Kennungen
Brukinsa · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenBrukinsa · 4.8 · Reporting of suspected adverse reactions
Eintrag öffnenBrukinsa · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenBrukinsa · 4.8 · Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows con
Eintrag öffnenBrukinsa · 4.8 · Summary of the safety profile
Eintrag öffnenBrukinsa · 4.8 · Summary of the safety profile
Eintrag öffnenBrukinsa · 4.8 · Table 3: Adverse reactions of zanubrutinib monotherapy reported in clinical studies in patients with B-cell ma
Eintrag öffnenBrukinsa · 4.8 · Table 4: Adverse reactions of zanubrutinib in combination with obinutuzumab reported in clinical study BGB-311
Eintrag öffnenBrukinsa · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenBrukinsa · 4.8 · Tabulated list of adverse reactions
Eintrag öffnenBrukinsa · 4.8 · The most common Grade 3 or higher adverse reactions (>3%) of zanubrutinib in combination with obinutuzumab wer
Eintrag öffnenBrukinsa · 4.8 · The most common Grade 3 or higher adverse reactions (>3%) of zanubrutinib monotherapy were neutropenia§ (21%),
Eintrag öffnenBrukinsa · 4.8 · The most common Grade 3 or higher adverse reactions (>3%) of zanubrutinib monotherapy were neutropenia§ (21%),
Eintrag öffnenBrukinsa · 4.8 · The most commonly occurring adverse reactions (≥20%) of zanubrutinib monotherapy were upper respiratory tract
Eintrag öffnenBrukinsa · 4.8 · The most commonly occurring adverse reactions (≥20%) of zanubrutinib monotherapy were upper respiratory tract
Eintrag öffnenBrukinsa · 4.8 · The safety profile of zanubrutinib in combination with obinutuzumab is based on ROSEWOOD study data from 143 p
Eintrag öffnenBrukinsa · 4.8 · The safety profile of zanubrutinib in combination with obinutuzumab is based on ROSEWOOD study data from 143 p
Eintrag öffnenBrukinsa · 4.8 · The safety profile of zanubrutinib monotherapy is based on pooled data from 1 550 patients with B- cell malign
Eintrag öffnenBrukinsa · 4.8 · The safety profile of zanubrutinib monotherapy is based on pooled data from 1 550 patients with B- cell malign
Eintrag öffnenBrukinsa · 4.8 · Upper respiratory tract infection§ Very Common (36) 2 Infections and infestations Pneumonia§# Very Common (24)
Eintrag öffnen